A single dose of psilocybin significantly decreased depression and anxiety in people with cancer, according to a new study. Psilocybin is a chemical in certain mushrooms that causes hallucinogenic ...
A single dose of psilocybin combined with psychological support can provide lasting relief from depression and anxiety in patients with cancer. In a phase 2 clinical trial, more than half of patients ...
Researchers at the US health centre Penn Medicine have found specific brain circuits are affected by psilocybin, the active compound in certain psychedelic mushrooms, opening new ways to treat pain ...
Some New York lawmakers are interested in changing state laws about psilocybin, the psychoactive drug found in so-called “magic mushrooms,” to allow the substance to be used to treat a wide variety of ...
Learn more about participating in clinical trials being conducted by NYU Langone’s Center for Psychedelic Medicine.
The trial tested efficacy outcomes at 2 years for 28 patients enrolled in the phase 2 trial. HealthDay News — For cancer patients with a major depressive disorder, a single dose of psilocybin combined ...
Hosted on MSN
Single dose of psilocybin provides lasting relief from depression and anxiety in cancer patients
A clinical trial examined the effects of psilocybin combined with psychological support on cancer patients diagnosed with major depressive disorder. Results showed that a single dose of psilocybin had ...
In 1984, my grandfather took his last breath and shuffled off this mortal coil after a nasty bout with cancer. I was only 13 at the time, and probably didn’t fully understand the pain he was in. Not ...
A single dose of psilocybin combined with psychological support reduced anxiety and depression for 2 years in people with cancer and major depressive disorder in a phase II trial. (Cancer) The ...
Study findings could inform therapies for other conditions involving dysregulated brain circuits, such as addiction or PTSD.
UCLA study finds magic mushrooms can help curb the anxiety of advanced cancer. Sept. 7, 2010— -- When 55-year-old California software developer Pam Sakuda was diagnosed with metastic colon cancer ...
About half of patients had sustained reduction in depression and anxiety up to two years after psilocybin and psychotherapy. (HealthDay News) — For cancer patients with a major depressive disorder, a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results